Beijing Silent on Sale of 10M Pfizer Vaccine Doses to Foxconn, TSMC
A Chinese Foreign Affairs Ministry spokesperson declined comment on contracts signed by Foxconn and Taiwan Semiconductor Manufacturing Co. to buy 5 million doses each of the Pfizer-BioNTech COVID-19 vaccine from China's Fosun Pharma for distribution to the Taiwanese public, after…
Sign up for a free preview to unlock the rest of this article
Export Compliance Daily combines U.S. export control news, foreign border import regulation and policy developments into a single daily information service that reliably informs its trade professional readers about important current issues affecting their operations.
Taiwan alleged Beijing blocked a direct Fosun-Taipei government sale from going through. “This is not a question concerning foreign affairs,” the spokesperson told his regular news conference Monday. “I want to stress that we truly care about the welfare of our Taiwan compatriots and hope they can have early access to the direly needed vaccine.” After two months of vaccine procurement delays, “I am very pleased to finally be able to give an account to the public today that the relevant contracts have been signed,” wrote Foxconn CEO Terry Gou on Facebook Monday, according to an unofficial English translation. Less than 1% of the Taiwanese population was fully vaccinated against COVID-19 through Thursday, reported the research website Our World in Data.